首页 | 本学科首页   官方微博 | 高级检索  
     

宫颈细胞 HPV E6/E7 mRNA 检测在宫颈病变诊断中的价值
引用本文:严雪梅,洪颖. 宫颈细胞 HPV E6/E7 mRNA 检测在宫颈病变诊断中的价值[J]. 山东医药, 2014, 0(23): 60-63
作者姓名:严雪梅  洪颖
作者单位:[1]南京医科大学鼓楼临床医学院,南京210000 [2]上海梅山医院 ,南京210000 [3]南京鼓楼医院,南京210000
基金项目:南京市医学科技发展项目(YKK13189).
摘    要:目的:评价高危型人乳头状瘤病毒( HPV) E6/E7 mRNA检测对宫颈病变的诊断价值。方法520例患者采用b-DNA技术检测HPV E6/E7 mRNA,并用宫颈液基细胞学( TCT)行宫颈细胞学检查,对其中任何一项阳性者做阴道镜下宫颈活组织检查,以组织病理为金标准,计算HPV E6/E7 mRNA阳性对高级别宫颈上皮内瘤样病变( CIN)、宫颈浸润癌诊断的灵敏度、特异度、阳性预测值、阴性预测值,并与TCT检查进行比较。结果520例患者中HPV E6/E7 mRNA阳性158例, TCT异常222例。 TCT 异常者中HPV E6/E7 mRNA阳性率较TCT 正常者中HPV E6/E7 mRNA阳性率高(P<0.05)。146例慢性宫颈炎、CINⅠ级患者与124例高级别CIN、宫颈浸润癌患者中HPV E6/E7 mRNA阳性率比较,P<0.05。 HPV E6/E7 mRNA阳性对高级别CIN及宫颈浸润癌诊断的灵敏度、特异度、阳性预测值、阴性预测值分别为74.19%、83.33%、58.23%、71.43%,TCT 检查分别为81.53%、69.44%、81.45%、92.28%,两者特异度及阳性预测值比较, P均<0.05。结论在宫颈癌筛查中检测高危型HPV E6/E7 mRNA对预测高级别CIN,尤其对评估癌症风险有重要的临床价值。

关 键 词:b-DNA技术  人乳头状瘤病毒  E6基因  E7基因  宫颈高度上皮内瘤样病变

Clinical value of branch-DNA technique for human papillomavirus E6/E7 mRNA detection in cervical lesions
YAN Xue-mei,HONG Ying. Clinical value of branch-DNA technique for human papillomavirus E6/E7 mRNA detection in cervical lesions[J]. Shandong Medical Journal, 2014, 0(23): 60-63
Authors:YAN Xue-mei  HONG Ying
Affiliation:1 Nanjing Drum Tower Clinical College of Nanjing Medical University, Nanjing 210000, China)
Abstract:Objective To evaluate the clinical value of human papillomavirus ( HPV) E6/E7 mRNA detection in diagnosis of cervical lesions.Methods Totally 520 patients were examined with b-DNA technology to detect HR-HPV E6/E7mRNA and the cervical cytological examination with liquid-based cytology (TCT).Women with cytologi-cal abnormalities or HR-HPV E6/E7 mRNA positive results underwent colposcopy and cervical biopsy .We compared the sensitivity, specificity, positive predictive value and negative predictive value between the HPV E6/E7mRNA and TCT for the detection of high-grade cervical intraepithelial neoplasias ( CIN) and cervical cancer ( CC) .Results A-mong 520 patients, 158 cases were found HPV E6/E7mRNA positive and 222 cases got TCT abnormal.The positive rate of HPV E6/E7 mRNA with abnormal results in TCT abnormal group was higher than that of the normal group ( P〈0.05) .There was difference in the positive rate of HPV E6/E7mRNA between the group who got chronic cervicitis or low-grade intraepithelial neoplasias (CINⅠ) and the group who got high-grade CIN and CC (P〈0.05).For the detection of high-grade CIN and CC, the sensitivity of HPVE6/E7 mRNA and TCT was 74.19% and 81.53%, re-spectively; the specificity was 83.33% and 69.44%, respectively; the positive predictive value was 58.23% and 81.45%, respectively; and the negative predictive value was 71.43% and 92.28% respectively.The specificity and positive predictive value was statistically different between the two groups (all P〈0.05).Conclusion In cervi-cal cancer screening, high-risk HPV E6/E7 mRNA detection in predicting high-grade CIN has high clinical value, es-pecially for assessing the risk of malignancy.
Keywords:b-DNA technology  human papillomavirus  E6 gene  E7 gene  high-grade cervical intraepithelial neo-plasias
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号